ATRICURE INC (ATRC) — insider trading
Health Care · NASDAQ
ATRICURE INC (ATRC) has 12 reported SEC Form 4 insider transactions in our data, including 1 open-market sale among the most recent 12 (latest 2026-06-30).
Recent Form 4 transactions
| Date | Insider | Role | Type | Shares | Price | Value | Filing |
|---|---|---|---|---|---|---|---|
| 2026-06-30 | Privitera Salvatore | Officer (Chief Technical Officer) | Grant / award / vesting | 636 | $23.78 | $15.1K | Form 4 |
| 2026-06-30 | Seith Douglas J | Officer (Chief Operating Officer) | Grant / award / vesting | 527 | $23.78 | $12.5K | Form 4 |
| 2026-06-30 | Dahlquist Karl S. | Officer (Chief Legal Officer) | Grant / award / vesting | 636 | $23.78 | $15.1K | Form 4 |
| 2026-06-30 | Doraiswamy Vinayak | Officer (Chief Scientific Officer) | Grant / award / vesting | 636 | $23.78 | $15.1K | Form 4 |
| 2026-06-30 | CARREL MICHAEL H | Director, Officer (President, CEO, & Director) | Grant / award / vesting | 636 | $23.78 | $15.1K | Form 4 |
| 2026-05-20 | Prange Karen | Director | Open-market sale | 3,000 | $28.65 | $86.0K | Form 4 |
| 2026-05-18 | GROVES REGINA E | Director | Grant / award / vesting | 6,144 | $0.00 | $0 | Form 4 |
| 2026-05-18 | JOHNSON B KRISTINE | Director | Grant / award / vesting | 6,144 | $0.00 | $0 | Form 4 |
| 2026-05-18 | Nachman Shlomo | Director | Grant / award / vesting | 6,144 | $0.00 | $0 | Form 4 |
| 2026-05-18 | Yuen Maggie | Director | Grant / award / vesting | 6,144 | $0.00 | $0 | Form 4 |
| 2026-05-18 | Telman Deborah H | Director | Grant / award / vesting | 6,144 | $0.00 | $0 | Form 4 |
| 2026-05-18 | Prange Karen | Director | Grant / award / vesting | 6,144 | $0.00 | $0 | Form 4 |
Ask the chat about ATRC's insider activity →
Transaction types are the SEC Form 4 codes: open-market purchases (P) and sales (S) are the only rows that reflect open-market conviction. Awards/vesting (A), option exercises (M/X/C), shares withheld for taxes (F) and gifts (G) are compensation or mechanical, not buying or selling on the open market. Sales may be planned and non-discretionary (e.g. a Rule 10b5-1 plan); open-market buying is not a recommendation to buy. Informational only — not financial advice.
Source: SEC EDGAR Form 3/4/5. See the full company profile: ATRICURE INC (ATRC).
Last updated 2026-06-30 (most recent filing date).
Informational only — NOT financial advice. Insider filings are sourced from SEC EDGAR and shown with their reported dates.